Company continues regulatory engagement in the US and overseas markets
The partnership comes as price remains the main barrier to consumer adoption.
Leadership changes and falling sales add pressure to an already difficult year
The investment will support regulatory approvals and early commercial sales for the company.
New facility in Cape Town to support domestic and international biologics projects.